Results 1 to 10 of about 3,223,608 (377)

Psychometric and clinical evaluation of schizophrenia remission criteria in outpatients with psychotic disorders [PDF]

BMC Psychiatry, 2023
Background Psychotic disorders such as schizophrenia have debilitating effects on health and functioning. Given symptomatic remission’s recent emergence as a viable treatment goal, the Remission in Schizophrenia Working Group’s criteria (RSWG-cr), based ...
Karolina Sakinyte, Christopher Holmberg
doaj   +2 more sources

Exposotypes in psychotic disorders [PDF]

Sci Rep
AbstractPsychiatry lags in adopting etiological approaches to diagnosis, prognosis, and outcome prediction compared to the rest of medicine. Etiological factors such as childhood trauma (CHT), substance use (SU), and socioeconomic status (SES) significantly affect psychotic disorder symptoms.
Yassin W, Kromenacker B, Green J, Tamminga C, del Re E, Seif P, Xia C, Alliey-Rodriguez N, Gershon E, Clementz B, Pearlson G, Keedy S, Ivleva E, Hill S, McDowell J, Keshavan M.   +15 more
europepmc   +3 more sources

Group Motivational Interviewing as a Psychotherapeutic Intervention for Dual Diagnosis Patients Living with a Psychotic Disorder: Critique of the Literature [PDF]

, 2012
Studies indicate that 50% of individuals living with a psychotic disorder also meet Diagnostic and Statistical Manual IV Text Revision (DSM-IV-TR) criteria for substance abuse disorder during their lifetime (Green, Drake, Brunette, & Noordsy, 2007 ...
Alexander D Stauder
openalex   +3 more sources

Ekbom syndrome: a case report

European Psychiatry, 2022
Introduction Ekbom syndrome is a clinical term for delusional parasitosis, a condition characterized by the belief that one’s skin is infested by invisible parasites.
D. Bosnjak Kuharic, M. Cvitanic Mazuran, D. Polšek, M. Herceg, A. Jambrosic Sakoman   +4 more
doaj   +1 more source

Schizophrenia and myasthenia gravis: a case report

European Psychiatry, 2023
Introduction Despite a variety of pharmacological and psychotherapeutic interventions, treatment of schizophrenia can still be challenging, even more when certain comorbidities are present.
D. Bošnjak Kuharić, T. Sabo, A. Jambrošić Sakoman, M. Herceg   +3 more
doaj   +1 more source

The Influence of Probiotic Supplementation on Depression, Anxiety, and Stress Level, as well as Inflammation, Anthropometric and Metabolic Parameters in Patients with Depressive Disorders - preliminary results of an RCT

European Psychiatry, 2023
Introduction There is a huge need to search for new treatment options for depression but as well as its comorbidities. Particularly, depression and metabolic abnormalities often coexist, while a pathophysiological overlap, including microbiota changes ...
O. Gawlik-Kotelnicka, A. Skowrońska, A. Margulska, D. Strzelecki   +3 more
doaj   +1 more source

Psychotic disorders.

Psychosis is a debilitating group of symptoms that affects an individual at the same time and occurs over a period of time. These symptoms often include disturbances in behaviour, the thinking process, thought content, perception, affect, and mood.
Olaoluwa Okusaga, Gabriela Austgen
  +10 more sources

Family support in treatment of patients diagnosed with schizophrenia: a case report

European Psychiatry, 2022
Introduction Schizophrenia is often accompanied by functional deterioration which can impede a person‛s everyday activities. Families are an important part in providing care for their ailed member‚ but often lack resources to deal with different ...
A. Jambrosic Sakoman, D. Bosnjak Kuharic, I. Zegura   +2 more
doaj   +1 more source

Impact of cannabis decriminalization on selected psychotic disorders: a retrospective analysis at “Center for Mental Health and Prevention of Addiction” (2013-2023) in Tbilisi [PDF]

Eur Psychiatry
Jibuti N, Jishkariani L, Jmukhadze K, Gigolashvili K, Zurabashvili D, Lejava G.   +5 more
europepmc   +3 more sources

RNA-seq co-expression network analysis reveals anxiolytic behavior of mice with Efnb2 knockout in parvalbumin+ neurons

Molecular Brain, 2021
Anxiety disorders are the most common psychiatric disorders, and the change in the activity of the prefrontal cortex (PFC) is considered as the underlying pathological mechanism. Parvalbumin-expressing (PV+) inhibition contributes to the overall activity
Ying Sun, Le Ma, Jianhua Chen, Weidi Wang, Shiyu Peng, Ying Cheng, Yu Zhang, Jinghong Chen, Peijun Ju   +8 more
doaj   +1 more source